← Back to patent-cliff list
CAS 3257-18-9
S-Benzyl-N-[(benzyloxy)carbonyl]-L-cysteine
Codes: Reduced Glutathione Sodium-007
Application context (from source-drug indications)
Acute respiratory distress syndromeReduced Glutathione SodiumLiver diseaseReduced Glutathione Sodium酒精性肝炎Reduced Glutathione Sodium酒精性肝硬化Reduced Glutathione Sodium酒精性脂肪肝病Reduced Glutathione SodiumSepsisReduced Glutathione Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Reduced Glutathione Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
L-Cysteine hydrochloride→(2R)-2-Amino-3-(benzylsulfanyl)propanoic acid→S-Benzyl-N-(tert-butoxycarbonyl)-L-cysteine→S-Benzyl-N-[(benzyloxy)carbonyl]-L-cysteine→Ethyl 2-aminoacetate hydrochloride→Ethyl S-benzyl-N-(tert-butoxycarbonyl)-L-cysteinylglycinate→Ethyl S-benzyl-N-[(benzyloxy)carbonyl]-L-cysteinylglycinate→S-Benzyl-L-cysteinylglycine→Benzyl [(3S)-2,6-dioxooxan-3-yl]carbamate→N-[(Benzyloxy)carbonyl]-L-gamma-glutamyl-S-benzyl-L-cysteinylglycine→L-gamma-Glutamyl-S-benzyl-L-cysteinylglycine→L-alpha-Aminoglutaric acid→N-[(Benzyloxy)carbonyl]-L-glutamic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.